Literature DB >> 8695155

Immunohistochemical evaluation of lymph node micrometastases from breast cancer.

A Tsuchiya1, K Sugano, I Kimijima, R Abe.   

Abstract

The lymph node micrometastasis was retrospectively immunohistochemically investigated in 185 patients with node-negative breast cancer and compared with the routine conventional findings. The monoclonal antibodies to epithelial membrane antigen (EMA) and mucinous-like carcinoma antigen (MCA) were used. Of 19 EMA-positive cases, 16 were false positive. Therefore only 3 cases were found to show staining with both EMA and MCA. The patients are all living and well and free of recurrence. No micrometastasis was immunhistochemically demonstrated in 11 node-negative breast cancer patients with subsequent metastases. The results of the present study indicate that the detection rate containing occult cells afforded by conventional routine evaluation is sufficient, at least in Japanese.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8695155     DOI: 10.3109/02841869609109916

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  4 in total

1.  A murine model of bone marrow micrometastasis in breast cancer.

Authors:  Barbara O'Kane Murphy; Shantaram Joshi; Anne Kessinger; Elizabeth Reed; J Graham Sharp
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 2.  Molecular pathology of tumor metastasis. II. Molecular staging and differential diagnosis.

Authors:  József Tímár; Orsolya Csuka; Zsolt Orosz; András Jeney; László Kopper
Journal:  Pathol Oncol Res       Date:  2003-01-06       Impact factor: 3.201

3.  The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis.

Authors:  J W Clark; L Snell; R P Shiu; F W Orr; N Maitre; C P Vary; D J Cole; P H Watson
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

4.  Prognostic significance of occult lymph node metastases in breast cancer: a meta-analysis.

Authors:  Guixin Wang; Shuhao Zhang; Meiling Wang; Lin Liu; Yaqian Liu; Lianjun Tang; He Bai; Haidong Zhao
Journal:  BMC Cancer       Date:  2021-07-30       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.